Leukos Biotech

develops diagnostic tools for acute myeloid leukemia and other hematological malignancies...
Read more
Leukos Biotech CEO: Enrique Llaudet Carles

CEO

Enrique Llaudet Carles

CEO Approval Rating

70/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$3.9M

Trending Companies